Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00940615
Other study ID # B6859-M
Secondary ID
Status Terminated
Phase N/A
First received July 14, 2009
Last updated June 25, 2015
Start date September 2009
Est. completion date September 2010

Study information

Verified date June 2015
Source VA Office of Research and Development
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

The current project will examine the effects of aerobic exercise on cognition among a group of veterans who have suffered a mild traumatic brain injury.


Description:

There is substantial evidence that a large number of individuals who experience TBI will demonstrate life-long deficits in cognitive or social functions. An estimated 80-90,000 Americans with TBI suffer life-long impairment of physical, cognitive, and psychosocial skills to the degree that they are unable to return to school or work. Research on rehabilitation for mTBI has been minimal and typically has focused on speech, pain management, dizziness, fatigue, irritability, and sensory disorders. The results of the few studies that have examined long-term cognitive effects of mTBI have offered conflicting results. The current research will investigate the efficacy of an aerobic exercise intervention among individuals with mild traumatic brain injury (mTBI). This project will examine changes in fractional anisotropy (FA) values and cognitive functioning among individuals diagnosed with mTBI in a monitored aerobic exercise regimen, versus a low impact stretching and toning control group.


Recruitment information / eligibility

Status Terminated
Enrollment 24
Est. completion date September 2010
Est. primary completion date September 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- Anyone between 18 and 50 years of age,

- from the geographic region served by the Malcolm Randall-North Florida-South Georgia VAMC,

- who have sustained a TBI and demonstrate impairment on neuropsychological assessment (criteria for mTBI will be defined as a loss of consciousness for not more than 30 minutes and post-trauma amnesia of not more than 24 hours).

Exclusion Criteria:

- TBI occurring less than 6 months or greater than 5 years prior to enrollment,

- any metal implants or shrapnel that may put them at risk for injury during an MRI scan,

- significant cognitive impairment (MMSE<24),

- history of stroke,

- B-12 deficiency,

- hypothyroidism,

- organ failure (renal, hepatic, cardiac, or lung),

- substance abuse,

- seizures,

- or any limitation that would preclude them from safely engaging in the aerobic exercise regimen.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
aerobic exercise
, participants assigned to the exercise treatment group of the proposed study will participate in an aerobic exercise regimen of brisk walking on a treadmill for a 60 minute interval, three times a week
stretching/toning
Individuals in the control group will participate in a low intensity stretching and toning session for 60 minutes, three times a week

Locations

Country Name City State
United States North Florida/South Georgia Veterans Health System Gainesville Florida

Sponsors (1)

Lead Sponsor Collaborator
VA Office of Research and Development

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diffusion Tensor Imaging 16 weeks No
Secondary Trail Making Test - Part A 16 weeks No
Secondary Symbol Search 16 weeks No
Secondary California Verbal Learning Test - Second Edition (CVLT-II). 16 weeks No
Secondary Brief Visual Memory Test - Revised (BVMT-R). 16 weeks No
Secondary Adaptive Digit Ordering Test (DOT-A). 16 weeks No
Secondary Continuous Performance Test of Attention (CPT-A). 16 weeks No
Secondary Delis-Kaplin Executive Function System Tower Test 16 weeks No
Secondary Trail Making Test - Part B. 16 weeks No
Secondary Controlled Oral Word Association Test (COWAT). 16 weeks No
Secondary Boston Naming Test (BNT). 16 weeks No
Secondary Judgment-Line Orientation (JLO). 16 weeks No
Secondary Grooved Pegboard Test 16 weeks No
Secondary Hand Dynamometer 16 weeks No
Secondary Finger Tapping Test 16 weeks No
See also
  Status Clinical Trial Phase
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT05503316 - The Roll of Balance Confidence in Gait Rehabilitation in Persons With a Lesion of the Central Nervous System N/A
Completed NCT04356963 - Adjunct VR Pain Management in Acute Brain Injury N/A
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Terminated NCT03698747 - Myelin Imaging in Concussed High School Football Players
Recruiting NCT05130658 - Study to Improve Ambulation in Individuals With TBI Using Virtual Reality -Based Treadmill Training N/A
Recruiting NCT04560946 - Personalized, Augmented Cognitive Training (PACT) for Service Members and Veterans With a History of TBI N/A
Completed NCT05160194 - Gaining Real-Life Skills Over the Web N/A
Recruiting NCT02059941 - Managing Severe Traumatic Brain Injury (TBI) Without Intracranial Pressure Monitoring (ICP) Monitoring Guidelines N/A
Recruiting NCT03940443 - Differences in Mortality and Morbidity in Patients Suffering a Time-critical Condition Between GEMS and HEMS
Recruiting NCT03937947 - Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study
Completed NCT04465019 - Exoskeleton Rehabilitation on TBI
Recruiting NCT04530955 - Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS) N/A
Recruiting NCT03899532 - Remote Ischemic Conditioning in Traumatic Brain Injury N/A
Suspended NCT04244058 - Changes in Glutamatergic Neurotransmission of Severe TBI Patients Early Phase 1
Completed NCT03307070 - Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury N/A
Recruiting NCT04274777 - The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders
Withdrawn NCT05062148 - Fundamental and Applied Concussion Recovery Modality Research and Development: Applications for the Enhanced Recovery N/A
Withdrawn NCT04199130 - Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI N/A
Withdrawn NCT03626727 - Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia Early Phase 1